Estados financieros detallados de Jaguar Health, Inc. (JAGX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Jaguar Health, Inc. registró ingresos de $11.5M en el último ejercicio fiscal, con un CAGR de 5 años del 4.2%.
Márgenes de los últimos 12 meses: margen bruto 82.3%, margen operativo -90.2%, margen neto -131.8%.
Al precio actual de $0.23, JAGX presenta beneficios negativos (P/E no significativo) y un ROE del 7.63%. La capitalización bursátil es de $0M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $141523 | $4.4M | $4.4M | $5.8M | $9.4M | $4.3M | $12.0M | $9.8M | $11.7M | $11.5M |
| Coste de Ventas | $51966 | $880405 | $2.8M | $3.8M | $3.3M | $2.3M | $2.0M | $2.0M | $2.0M | $3.8M |
| Beneficio Bruto | $89557 | $3.5M | $1.7M | $2.0M | $6.1M | $2.0M | $9.9M | $7.7M | $9.7M | $7.7M |
| I+D | $7.2M | $4.3M | $5.2M | $5.8M | $6.4M | $15.1M | $17.6M | $18.6M | $16.5M | $25.0M |
| Generales y Administrativos | $6.5M | $14.3M | $22.1M | $20.4M | $21.0M | $26.0M | $26.7M | $23.0M | $24.0M | $26.0M |
| Gastos Operativos | $13.7M | $18.6M | $27.3M | $30.9M | $32.8M | $42.7M | $44.4M | $42.0M | $40.6M | $52.8M |
| Beneficio Operativo | -$13.6M | -$34.2M | -$30.8M | -$28.9M | -$26.6M | -$40.7M | -$34.4M | -$34.3M | -$30.8M | -$45.1M |
| EBITDA | -$13.7M | -$11.1M | -$27.8M | -$30.9M | -$28.7M | -$42.4M | -$33.4M | -$32.8M | -$36.7M | -$51.7M |
| Gastos por Intereses | $985549 | $1.2M | $2.6M | $5.7M | $2.8M | $8.4M | $12.7M | $6.4M | $231000 | -$67000 |
| Beneficio Antes de Impuestos | -$14.7M | -$35.1M | -$32.1M | -$38.5M | -$33.8M | -$52.6M | -$48.4M | -$41.9M | -$39.3M | -$54.0M |
| Impuestos | 0 | -$13.2M | 0 | $10000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$14.7M | -$22.0M | -$32.1M | -$38.5M | -$33.8M | -$52.6M | -$47.5M | -$41.3M | -$38.5M | -$53.4M |
| BPA | $-16744218756.00 | $-6325593752.00 | $-1810550318.00 | $-106403456.00 | $-11814153.00 | $-4631759.00 | $-1899528.00 | $-93992.00 | $-4574.07 | $-803.95 |
| BPA Diluido | $-16744218756.00 | $-6325593752.00 | $-1810550318.00 | $-106403456.00 | $-11814153.00 | $-4631759.00 | $-1899528.00 | $-93992.00 | $-4574.07 | $-803.95 |
| Acciones en Circulación (Diluidas) | 0 | 0 | 0 | 0 | $3 | $11 | $25 | $439 | $8415 | $66640 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $950979 | $520698 | $2.6M | $3.5M | $8.1M | $17.1M | $5.5M | $6.5M | $8.0M | $968000 |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $304611 | $469038 | $1.0M | $1.7M | $4.6M | $2.1M | $2.5M | $2.2M | $1.6M | $1.7M |
| Inventario | $412754 | $2.1M | $3.3M | $2.1M | $2.8M | $4.9M | $7.0M | $9.2M | $10.3M | $8.6M |
| Activos Corrientes | $2.6M | $3.8M | $8.1M | $9.5M | $17.8M | $28.4M | $22.3M | $28.0M | $32.2M | $20.3M |
| Inmovilizado Material | $885945 | $1.2M | $760617 | $710000 | $677000 | $1.7M | $1.7M | $1.7M | $1.4M | $1.5M |
| Fondo de Comercio | 0 | $5.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | $33.4M | $31.7M | $26.0M | $24.3M | $22.7M | $22.4M | $20.1M | $18.5M | $16.0M |
| Activos Totales | $3.6M | $43.6M | $41.0M | $36.4M | $42.8M | $53.3M | $47.5M | $50.8M | $53.4M | $38.3M |
| Cuentas por Pagar | $517000 | $7.4M | $5.4M | $5.4M | $4.8M | $4.9M | $5.8M | $5.0M | $5.3M | $8.7M |
| Deuda a Corto | $2.1M | $5.4M | $16.1M | $6.8M | $3.8M | $3.2M | $15.9M | $4.9M | $12.0M | $27.4M |
| Pasivos Corrientes | $4.2M | $15.4M | $26.7M | $15.4M | $13.2M | $15.5M | $30.3M | $14.0M | $19.7M | $40.7M |
| Deuda a Largo | $1.8M | $11.0M | 0 | $450000 | $12.4M | $25.0M | $17.7M | $31.0M | $23.5M | $15.1M |
| Pasivos Totales | $6.0M | $26.4M | $35.7M | $25.7M | $25.6M | $41.4M | $48.8M | $45.9M | $46.9M | $57.0M |
| Reservas | -$40.4M | -$62.4M | -$94.6M | -$133.1M | -$166.9M | -$219.5M | -$266.9M | -$308.2M | -$346.5M | -$399.9M |
| Patrimonio Neto | -$2.5M | $17.3M | $5.4M | $10.7M | $17.2M | $11.6M | -$657000 | $5.0M | $7.3M | -$17.3M |
| Deuda Total | $3.9M | $16.4M | $16.1M | $7.6M | $16.2M | $29.4M | $34.8M | $37.1M | $36.5M | $43.6M |
| Deuda Neta | $2.9M | $15.9M | $13.5M | $4.1M | $8.1M | $12.3M | $29.4M | $30.6M | $28.5M | $42.6M |
| Capital Circulante | -$1.6M | -$11.6M | -$18.5M | -$5.9M | $4.6M | $13.0M | -$8.0M | $14.0M | $12.5M | -$20.3M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$14.7M | -$22.0M | -$32.1M | -$38.5M | -$33.8M | -$52.6M | -$49.1M | -$41.9M | -$39.0M | -$15.4M |
| Amortizaciones | $47494 | $584339 | $1.3M | $1.9M | $2.3M | $1.8M | $2.3M | $2.4M | $2.4M | $3000 |
| Compensación en Acciones | $717927 | $814613 | $2.0M | $3.0M | $2.8M | $4.0M | $3.3M | $2.1M | $1.6M | -$810000 |
| Cambio en Capital Circulante | -$1.1M | $4.1M | -$925099 | -$662000 | -$3.5M | $2.3M | -$4.4M | -$11.1M | -$3.0M | $12.9M |
| Flujo de Caja Operativo | -$14.4M | -$9.8M | -$22.7M | -$20.5M | -$15.3M | -$35.0M | -$33.1M | -$33.2M | -$29.4M | $5.8M |
| Inversiones (CapEx) | -$104207 | 0 | -$6527 | 0 | -$7000 | -$6000 | -$1.7M | 0 | -$231000 | -$25000 |
| Adquisiciones | 0 | -$1.6M | 0 | 0 | 0 | $247000 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | -$30 | 0 | 0 | 0 | 0 | 0 | 0 | -$31.1M |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$14.5M | -$9.8M | -$22.7M | -$20.5M | -$15.3M | -$35.0M | -$34.8M | -$33.2M | -$29.6M | $5.8M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | +2981.6% | +1.3% | +30.8% | +62.5% | -53.8% | +175.8% | -18.4% | +19.8% | -1.5% | |
| Crecimiento Beneficio Neto (anual) | -49.1% | -46.3% | -19.9% | +12.3% | -55.6% | +9.8% | +13.0% | +6.8% | -38.8% | |
| Crecimiento BPA (anual) | +62.2% | +71.4% | +94.1% | +88.9% | +60.8% | +59.0% | +95.1% | +95.1% | +82.4% | |
| Cambio en Acciones (anual) | +247.1% | +120.0% | +1658.9% | +1815.1% | +691.9% | |||||
| Crecimiento FCF (anual) | +32.3% | -131.4% | +10.0% | +25.3% | -128.8% | +0.6% | +4.4% | +10.9% | +119.5% | |
| Margen Bruto | 63.3% | 79.8% | 37.4% | 33.9% | 65.1% | 46.2% | 83.1% | 79.1% | 83.3% | 67.2% |
| Margen Operativo | -9599.8% | -785.3% | -698.0% | -501.3% | -283.9% | -939.1% | -287.8% | -351.3% | -263.8% | -391.9% |
| Margen EBITDA | -9680.9% | -255.2% | -628.8% | -534.5% | -306.2% | -977.3% | -279.2% | -335.6% | -313.6% | -449.4% |
| Margen Neto | -10410.9% | -503.7% | -727.9% | -667.3% | -360.2% | -1213.3% | -396.9% | -423.1% | -329.3% | -464.2% |
| Margen FCF | -10258.4% | -225.3% | -514.9% | -354.2% | -162.9% | -806.8% | -290.9% | -340.6% | -253.4% | 50.2% |
| Tasa Impositiva Efectiva | -0.0% | 37.5% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-4672397.24 | $-3080142.17 | $-1392165.77 | $-75653.42 | $-3519.31 | $86.63 | ||||
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Acciones en Circulación (Básicas) | 0 | 0 | 0 | 0 | $3 | $11 | $25 | $439 | $8415 | $66640 |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | 762.51% |
| Rentabilidad sobre capital invertido | -109.75% |
| Rentabilidad sobre activos | -107.18% |
| Margen bruto | 82.31% |
| Margen operativo | -90.22% |
| Margen neto | -131.76% |
Salud financiera
| Deuda / Patrimonio | 2.52 |
| Ratio corriente | 0.69 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -0.18 | -0.09 | -0.03 | -0.03 | -0.27 | -0.29 | -0.06 | -0.03 | -0.19 | -0.04 |
| P/VC | 0.00 | 0.00 | 0.00 | 0.00 | 0.61 | 1.33 | -4.34 | 0.23 | 1.02 | -0.13 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 1.12 | 3.58 | 0.24 | 0.12 | 0.64 | 0.19 |
| Margen Bruto | 63.3% | 79.8% | 37.4% | 33.9% | 65.1% | 46.2% | 83.1% | 79.1% | 83.3% | 67.2% |
| Margen Operativo | -9599.8% | -785.3% | -698.0% | -501.3% | -283.9% | -939.1% | -287.8% | -351.3% | -263.8% | -391.9% |
| Margen Neto | -10410.9% | -503.7% | -727.9% | -667.3% | -360.2% | -1213.3% | -396.9% | -423.1% | -329.3% | -464.2% |
Empresas relacionadas: BDRX · CANF · CLDI · CNSP · GNPX · GRI · INM
Explorar sector: Healthcare · Biotechnology
Más secciones de JAGX: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones